Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-26

FDA Approved: LAMIVUDINE — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a supplemental application for Lamivudine from Strides Pharma Science Limited (ANDA 090457). This action confirms approval of a supplemental submis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)

Snippet

SUPPL AP for LAMIVUDINE (LAMIVUDINE)